RIPK1 protects hepatocytes from death in Fas-induced hepatitis

Scientific Reports

Volumn 7, Issue 1, 2017, Pages

  Filliol, Aveline ^a,b,c   Farooq, Muhammad ^a,b,c   Piquet Pellorce, Claire ^a,b,c   Genet, Valentine ^a,b,c   Dimanche Boitrel, Marie Thérèse ^a,b,c   Vandenabeele, Peter ^d,e   Bertrand, Mathieu J M ^d,e   Samson, Michel ^a,b,c   Le Seyec, Jacques ^a,b,c  

^a UNIVERSITÉ DE RENNES 1   (France)

^b UNIVERSITÉ DE RENNES 1   (France)

^c UNIVERSITÉ DE RENNES 1   (France)

^d DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^e GHENT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; FAS PROTEIN, MOUSE; GAMMA INTERFERON; RECEPTOR INTERACTING PROTEIN SERINE THREONINE KINASE; RIPK1 PROTEIN, MOUSE; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 6; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ANIMAL; CELL DEATH; DISEASE MODEL; GENETICS; HEPATITIS; KNOCKOUT MOUSE; LIVER CELL; LIVER FUNCTION TEST; METABOLISM; MOUSE; PATHOLOGY;

ANIMALS; BIOMARKERS; CELL DEATH; DISEASE MODELS, ANIMAL; FAS RECEPTOR; HEPATITIS; HEPATOCYTES; INTERFERON-GAMMA; LIVER FUNCTION TESTS; MICE; MICE, KNOCKOUT; RECEPTOR-INTERACTING PROTEIN SERINE-THREONINE KINASES; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR NECROSIS FACTOR-ALPHA;

EID: 85028040661     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-017-09789-8     Document Type: Article

References (41)

1. Kaneko, Y. et al. Augmentation of Valpha14 NKT cell-mediated cytotoxicity by interleukin 4 in an autocrine mechanism resulting in the development of concanavalin A-induced hepatitis. J Exp Med 191, 105-114 (2000).
2. Takeda, K. et al. Critical contribution of liver natural killer T cells to a murine model of hepatitis. Proc Natl Acad Sci USA 97, 5498-5503, doi: 10.1073/pnas.040566697 (2000).
3. Trautwein, C. et al. Concanavalin A-induced liver cell damage: Activation of intracellular pathways triggered by tumor necrosis factor in mice. Gastroenterology 114, 1035-1045 (1998).
4. Brenner, C., Galluzzi, L., Kepp, O. & Kroemer, G. Decoding cell death signals in liver inflammation. J Hepatol 59, 583-594, doi: 10.1016/j.jhep.2013.03.033 (2013).
5. Malhi, H., Guicciardi, M. E. & Gores, G. J. Hepatocyte death: A clear and present danger. Physiol Rev 90, 1165-1194, doi: 10.1152/physrev.00061.2009 (2010).
6. Wroblewski, R. et al. Opposing role of tumor necrosis factor receptor 1 signaling in T cell-mediated hepatitis and bacterial infection in mice. Hepatology 64, 508-521, doi: 10.1002/hep.28551 (2016).
7. Hong, F. et al. Opposing roles of STAT1 and STAT3 in T cell-mediated hepatitis: Regulation by SOCS. J Clin Invest 110, 1503-1513, doi: 10.1172/JCI15841 (2002).
8. Arshad, M. I. et al. TRAIL but not FasL and TNFalpha, regulates IL-33 expression in murine hepatocytes during acute hepatitis. Hepatology 56, 2353-2362, doi: 10.1002/hep.25893 (2012).
9. Leist, M. et al. The 55-kD tumor necrosis factor receptor and CD95 independently signal murine hepatocyte apoptosis and subsequent liver failure. Mol Med 2, 109-124 (1996).
10. Seino, K. et al. Contribution of Fas ligand to T cell-mediated hepatic injury in mice. Gastroenterology 113, 1315-1322 (1997).
11. Tagawa, Y., Sekikawa, K. & Iwakura, Y. Suppression of concanavalin A-induced hepatitis in IFN-gamma(-/-) mice, but not in TNFalpha(-/-) mice: Role for IFN-gamma in activating apoptosis of hepatocytes. J Immunol 159, 1418-1428 (1997).
12. Zheng, S. J., Wang, P., Tsabary, G. & Chen, Y. H. Critical roles of TRAIL in hepatic cell death and hepatic inflammation. J Clin Invest 113, 58-64, doi: 10.1172/JCI19255 (2004).
13. Huang, D. C. et al. Activation of Fas by FasL induces apoptosis by a mechanism that cannot be blocked by Bcl-2 or Bcl-x(L). Proc Natl Acad Sci USA 96, 14871-14876 (1999).
14. Ogasawara, J. et al. Lethal effect of the anti-Fas antibody in mice. Nature 364, 806-809, doi: 10.1038/364806a0 (1993).
15. Wanner, G. A. et al. Inhibition of caspase activity prevents CD95-mediated hepatic microvascular perfusion failure and restores Kupffer cell clearance capacity. FASEB J 13, 1239-1248 (1999).
16. Hsu, H., Huang, J., Shu, H. B., Baichwal, V. & Goeddel, D. V. TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex. Immunity 4, 387-396 (1996).
17. Stanger, B. Z., Leder, P., Lee, T. H., Kim, E. & Seed, B. RIP: A novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death. Cell 81, 513-523 (1995).
18. Chaudhary, P. M. et al. Death receptor 5, a new member of the TNFR family, and DR4 induce FADD-dependent apoptosis and activate the NF-kappaB pathway. Immunity 7, 821-830 (1997).
19. Lin, Y. et al. The death domain kinase RIP is essential for TRAIL (Apo2L)-induced activation of IkappaB kinase and c-Jun N-terminal kinase. Mol Cell Biol 20, 6638-6645 (2000).
20. Pasparakis, M. & Vandenabeele, P. Necroptosis and its role in inflammation. Nature 517, 311-320, doi: 10.1038/nature14191 (2015).
21. Ofengeim, D. & Yuan, J. Regulation of RIP1 kinase signalling at the crossroads of inflammation and cell death. Nat Rev Mol Cell Biol 14, 727-736, doi: 10.1038/nrm3683 (2013).
22. Silke, J., Rickard, J. A. & Gerlic, M. The diverse role of RIP kinases in necroptosis and inflammation. Nat Immunol 16, 689-697, doi: 10.1038/ni.3206 (2015).
23. Dillon, C. P. et al. RIPK1 blocks early postnatal lethality mediated by caspase-8 and RIPK3. Cell 157, 1189-1202, doi: 10.1016/j. cell.2014.04.018 (2014).
24. Gentle, I. E. et al. In TNF-stimulated cells, RIPK1 promotes cell survival by stabilizing TRAF2 and cIAP1, which limits induction of non-canonical NF-kappaB and activation of caspase-8. J Biol Chem 286, 13282-13291, doi: 10.1074/jbc.M110.216226 (2011).
25. Kelliher, M. A. et al. The death domain kinase RIP mediates the TNF-induced NF-kappaB signal. Immunity 8, 297-303 (1998).
26. Schneider, A. T. et al. RIPK1 Suppresses a TRAF2-Dependent Pathway to Liver Cancer. Cancer Cell 31, 94-109, doi: 10.1016/j. ccell.2016.11.009 (2017).
27. Vanlangenakker, N., Bertrand, M. J., Bogaert, P., Vandenabeele, P. & Vanden Berghe, T. TNF-induced necroptosis in L929 cells is tightly regulated by multiple TNFR1 complex I and II members. Cell Death Dis 2, e230, doi: 10.1038/cddis.2011.111 (2011).
28. Wong, W. W. et al. RIPK1 is not essential for TNFR1-induced activation of NF-kappaB. Cell Death Differ 17, 482-487, doi: 10.1038/cdd.2009.178 (2010).
29. Wang, L., Du, F. & Wang, X. TNF-alpha induces two distinct caspase-8 activation pathways. Cell 133, 693-703, doi: 10.1016/j. cell.2008.03.036 (2008).
30. Filliol, A. et al. RIPK1 protects from TNF-A mediated liver damage during hepatitis. Cell Death Dis 10;7(11), e2462, doi: 10.1038/cddis.2016.362 (2016).
31. Suda, J. et al. Knockdown of RIPK1 Markedly Exacerbates Murine Immune-Mediated Liver Injury through Massive Apoptosis of Hepatocytes, Independent of Necroptosis and Inhibition of NF-kappaB. J Immunol, doi: 10.4049/jimmunol.1600690 (2016).
32. Filliol, A. et al. RIPK1 protects hepatocytes from Kupffer cells-mediated TNF-induced apoptosis in mouse models of PAMP-induced hepatitis. J Hepatol, doi: 10.1016/j.jhep.2017.01.005 (2017).
33. Hasegawa, A. et al. Fas-disabling small exocyclic peptide mimetics limit apoptosis by an unexpected mechanism. Proc Natl Acad Sci U S A 101, 6599-6604, doi: 10.1073/pnas.0401597101 (2004).
34. Liedtke, C. et al. Loss of caspase-8 protects mice against inflammation-related hepatocarcinogenesis but induces non-apoptotic liver injury. Gastroenterology 141, 2176-2187, doi: 10.1053/j.gastro.2011.08.037 (2011).
35. Seki, E., Brenner, D. A. & Karin, M. A liver full of JNK: Signaling in regulation of cell function and disease pathogenesis, and clinical approaches. Gastroenterology 143, 307-320, doi: 10.1053/j.gastro.2012.06.004 (2012).
36. Corazza, N. et al. TRAIL receptor-mediated JNK activation and Bim phosphorylation critically regulate Fas-mediated liver damage and lethality. J Clin Invest 116, 2493-2499, doi: 10.1172/JCI27726 (2006).
37. Walczak, H. et al. Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat Med 5, 157-163, doi: 10.1038/5517 (1999).
38. Mizuhara, H. et al. Critical involvement of interferon gamma in the pathogenesis of T-cell activation-associated hepatitis and regulatory mechanisms of interleukin-6 for the manifestations of hepatitis. Hepatology 23, 1608-1615, doi: 10.1053/jhep.1996.v23. pm0008675184 (1996).
39. Watanabe, Y., Morita, M. & Akaike, T. Concanavalin A induces perforin-mediated but not Fas-mediated hepatic injury. Hepatology 24, 702-710, doi: 10.1053/jhep.1996.v24.pm0008781346 (1996).
40. Fulda, S. & Debatin, K. M. IFNgamma sensitizes for apoptosis by upregulating caspase-8 expression through the Stat1 pathway. Oncogene 21, 2295-2308, doi: 10.1038/sj.onc.1205255 (2002).
41. Hacker, S. et al. Histone deacetylase inhibitors cooperate with IFN-gamma to restore caspase-8 expression and overcome TRAIL resistance in cancers with silencing of caspase-8. Oncogene 28, 3097-3110, doi: 10.1038/onc.2009.161 (2009).